Detalhe da pesquisa
1.
The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation.
J Clin Pharmacol
; 49(3): 258-67, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19246727
2.
The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channel.
J Cardiovasc Pharmacol
; 54(1): 63-71, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19528813
3.
Criterion for board certification needs revision.
Ann Pharmacother
; 48(4): 552-3, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658638
4.
Ranolazine in the management of chronic stable angina.
Am J Health Syst Pharm
; 63(23): 2331-8, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17106005
5.
A preliminary assessment of the critical differences between novel oral anticoagulants currently in development.
J Clin Pharmacol
; 45(9): 1004-17, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16100294
6.
Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.
J Clin Pharmacol
; 45(1): 6-24, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15601801
7.
Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers.
Pharmacotherapy
; 25(5): 654-9, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15899726
8.
Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement.
Am J Health Syst Pharm
; 62(15): 1582-5, 2005 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16030367
9.
Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation.
Am J Cardiol
; 115(2): 196-201, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25465932
10.
Levosimendan: implications for clinicians.
J Clin Pharmacol
; 43(10): 1071-81, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14517189
11.
Anemia management in heart failure: a thick review of thin data.
Pharmacotherapy
; 24(6): 757-67, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15222666
12.
Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management.
Pharmacotherapy
; 23(8): 997-1020, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12921247
13.
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
JAMA
; 291(2): 216-21, 2004 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-14722148
14.
Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
J Clin Pharmacol
; 50(9): 986-1000, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124518
15.
A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic amines.
J Pharm Pract
; 23(3): 245-9, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21507821
16.
Drug-induced QT-interval prolongation: considerations for clinicians.
Pharmacotherapy
; 30(7): 684-701, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20575633
17.
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.
Br J Pharmacol
; 161(5): 1023-33, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20977453
18.
Are there ethnic differences in heart failure medication response?
Conn Med
; 67(10): 605-8, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14677341
19.
The impact of carvedilol on the defibrillation threshold.
Heart Lung
; 37(1): 67-71, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18206529
20.
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
Ann Noninvasive Electrocardiol
; 11(2): 163-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16630091